Examiners Amendment

TESSERA

Flagship VL58, Inc.

U.S. Trademark Application Serial No. 88642455 - TESSERA - F08172000300

To: TESSERA THERAPEUTICS, INC. (cxltrademarks@wolfgreenfield.com)
Subject: U.S. Trademark Application Serial No. 88642455 - TESSERA - F08172000300
Sent: April 28, 2020 12:59:39 PM
Sent As: ecom127@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

Office Action (Official Letter) About Applicant’s Trademark Application

 

U.S. Application Serial No. 88642455

 

Mark:  TESSERA

 

 

        

 

Correspondence Address:  

       Christina M. Licursi, Esq.

       WOLF GREENFIELD & SACKS, P.C.

       600 ATLANTIC AVENUE

       BOSTON MA 02210

       

 

 

 

 

 

Applicant:  TESSERA THERAPEUTICS, INC.

 

 

 

Reference/Docket No. F08172000300

 

Correspondence Email Address: 

       cxltrademarks@wolfgreenfield.com

 

 

 

EXAMINER’S AMENDMENT

 

 

Issue date:  April 28, 2020

 

USPTO database searched; no conflicting marks found.  The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d).  15 U.S.C. §1052(d); TMEP §704.02.

 

Application has been amended as shown below.  As agreed to by Christina M. Licursi on April 24, 2020, the examining attorney has amended the application as shown below.  Please notify the examining attorney immediately of any objections.  TMEP §707.  Otherwise, no response is required.  Id.  In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted.  37 C.F.R. §2.71(a).

 

The identification of goods is amended to read as follows:

 

International Class 1: “Chemical and biological agents for scientific and research use, namely, for manipulating or modifying DNA; technology for enabling the engineering and modification of DNA, namely, molecular and cellular biology reagents and assays for the modification of cells and DNA”

 

International Class 5: “Pharmaceutical preparations and therapeutic agents, namely, for gene therapy and DNA editing; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders”

 

See TMEP §§1402.01, 1402.01(e).

 

 

 

 

/Megan Mischler/

Trademark Examining Attorney

Law Office 127

(571) 272-9997

megan.mischler@uspto.gov

 

 

U.S. Trademark Application Serial No. 88642455 - TESSERA - F08172000300

To: TESSERA THERAPEUTICS, INC. (cxltrademarks@wolfgreenfield.com)
Subject: U.S. Trademark Application Serial No. 88642455 - TESSERA - F08172000300
Sent: April 28, 2020 12:59:40 PM
Sent As: ecom127@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

 

USPTO OFFICIAL NOTICE

 

Office Action (Official Letter) has issued

on April 28, 2020 for

U.S. Trademark Application Serial No. 88642455

 

Your trademark application has been reviewed by a trademark examining attorney.  As part of that review, the assigned attorney has issued an official letter.  Please follow the steps below.

 

(1)  Read the official letter.  No response is necessary.

 

(2)  Direct questions about the contents of the Office action to the assigned attorney below. 

 

/Megan Mischler/

Trademark Examining Attorney

Law Office 127

(571) 272-9997

megan.mischler@uspto.gov

 

Direct questions about navigating USPTO electronic forms, the USPTO website, the application process, the status of your application, and/or whether there are outstanding deadlines or documents related to your file to the Trademark Assistance Center (TAC).

 

 

 

GENERAL GUIDANCE

·       Check the status of your application periodically in the Trademark Status & Document Retrieval (TSDR) database to avoid missing critical deadlines.

 

·       Update your correspondence email address, if needed, to ensure you receive important USPTO notices about your application.

 

·       Beware of misleading notices sent by private companies about your application.  Private companies not associated with the USPTO use public information available in trademark registrations to mail and email trademark-related offers and notices – most of which require fees.  All official USPTO correspondence will only be emailed from the domain “@uspto.gov.”

 

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed